Recombinant proteins for therapy
- 1 December 1996
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 17 (12) , 450-456
- https://doi.org/10.1016/s0165-6147(96)01011-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- End-of-the-Year Potpourri—1996Human Gene Therapy, 1996
- New perspectives in lead generation II: Evaluating molecular diversityDrug Discovery Today, 1996
- New perspectives in lead generation I: Discovery of biological targetsDrug Discovery Today, 1996
- Biopharmaceutical R&D Success Rates and Development TimesNature Biotechnology, 1994
- Bolus Application of a Novel Recombinant Plasminogen Activator in Acute Myocardial Infarction Patients: Pharmacokinetics and Effects on the Hemostatic SystemAnnals of the New York Academy of Sciences, 1992
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991
- Designing CD4 immunoadhesins for AIDS therapyNature, 1989
- A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarctionJournal of the American College of Cardiology, 1987
- Second-generation plasminogen activatorsProtein Engineering, Design and Selection, 1987
- Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modulesCell, 1985